This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Ask-Upmark, E.: Life and death without ovaries. Acta med. scand.172, 129–135 (1962).
Ayd, F. J.: Current status of the major antidepressants. Amer. psychiat. Ass. Psychiat. Res. Rep. 213–216 (1959).
Bowlby, J.: Personality and mental illness. London: Kegan Paul, Trench, Trubner & Co. Ltd. 1940.
—: Separation anxiety. Int. J. Psycho-Anal.41, 89–113 (1960).
Clyde, D. J.: Manual for the Clyde Mood Scale. Biometric Laboratory University of Miami, Coral Gables, Fla. 1963.
Frank, J. D., L. H. Gliedman, S. D. Imber, A. R. Stone, andE. H. Nash: Patients' expectancies and relearning as factors determining improvement in psychotherapy. Amer. J. Psychiat.115, 961–968 (1959).
Freud, S.: On the grounds for detaching a particular syndrome from neurasthenia under the description ‘anxiety neurosis’. Stand. Ed.3, 90–115 (1895).
Goldman, D.: The effects of “energizers” on neurotic patients. Dis. nerv. Syst.23, 11, 1–8 (1962).
Klein, D. F., andM. Fink: Psychiatric reaction patterns to imipramine. Amer. J. Psychiat.119, 432–438 (1962a).
— —: Behavioral reaction patterns with phenothiazines. Arch. gen. Psychiat.7, 449–459 (1962b).
— —: Multiple item factors as change measures in psychopharmacology. Psychopharmacologia (Berl.)4, 43–52 (1963).
Lieberman, M. A., D. Stock, andR. M. Whitman: Self-perceptual patterns among ulcer patients. Arch. gen. Psychiat.1, 167–176 (1959).
Lorr, M., R. L.Jenkins, and J. Q.Holsopple: Multidimensional scale for rating psychiatric patients, hospital form. Veterans Adm. Tech. Bull. No. 10 (1953).
—,J. P. O'Connor, andJ. W. Stafford: The psychotic reaction profile. J. clin. Psych.16, 241–245 (1960).
Roth, M.: The phobic anxiety-depersonalization syndrome and some general aetiological problems in psychiatry. J. Neuropsychiat.1, 293–306 (1960).
Sargant, W.: The treatment of anxiety states and atypical depressions by the monoamine oxidase inhibitor drugs. J. Neuropsychiat.3, Suppl. 1, 96–103 (1962).
Aided, in part, by grants MY-02715 and MY-04798 of the National Institute of Mental Health, United States Public Health Service. The cooperation of Geigy Pharmaceuticals and Smith, Kline and French Laboratories is gratefully acknowledged.
About this article
Cite this article
Klein, D.F. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 5, 397–408 (1964). https://doi.org/10.1007/BF02193476
- Anxiety Syndrome